期刊文献+

促肾上腺皮质激素治疗婴儿痉挛55例临床研究 被引量:1

Clinical study of ACTH treatment in 55 children with infantile spasms
原文传递
导出
摘要 目的 总结首次应用促肾上腺皮质激素(ACTH)治疗婴儿痉挛的临床疗效、不良反应、用药前后的脑电图变化,为ACTH的普及应用提供临床借鉴。方法对我中心既往3年间收治的首次应用ACTH治疗的婴儿痉挛患儿的临床资料进行回顾性分析。结果(1)控制痉挛发作显效率为54.7%,好转率为15.1%,无效率为30.2%,且疗效与发病年龄、病程及病因有关;(2)不良反应有睡眠周期改变(85.5%)、皮肤颜色变深(81.8%)、心律不齐(65.5%)、血压升高(38.2%)、低钾血症(21.8%)、感染(20.0%)等;(3)用药前脑电图多以高峰节律紊乱为主要背景,用药两周后脑电图高峰节律消失41例(74.5%),好转14例(25.5%)。结论首次应用ACTH治疗婴儿痉挛疗效肯定,尤其可明显改善患儿高峰节律紊乱脑电背景,用药期间也存在一定的不良反应,应密切观察。 Objective To summarize efficacy,adverse effects,the EEG changes of children with infantile spasms before and after ACTH treatment. Methods Clinical datas of children with infantile spasms who accepted ACTH treatment from January 2006 to January 2009 were retrospectively analyzed. Results ( 1 ) Spastic attack significantly declined by 54. 7% ,improved by 15. 1% ,30. 2% were invalid,and the efficacy rate was related with onset age, disease course and etiology. (2) Adverse effects were change of sleep cycle (85.5%) ,skin becoming darker in color (81.8%), arrhythmia (65.5%), hypertension (38. 2% ), hypokalemia(21.8% ),and infection (20.0%). (3) The majority of main EEG background before treatment was hypasarrhythmia, after two weeks of ACTH treatment, the EEG background of hypasarrhythmia disappeared in 41 cases(74. 5% ) ,improved in 14 cases(25.5% ). Conclusion The efficacy of ACTH treatment for children with infantile spasms is centain, especially can significantly improve the background of hypasarrhythmia of EEG,dufing the period of drug use adverse effects maybe appear,which should be closely observed.
出处 《中国小儿急救医学》 CAS 2009年第4期344-345,348,共3页 Chinese Pediatric Emergency Medicine
关键词 婴儿痉挛 促肾上腺皮质激素 高峰失律 不良反应 Infantile spasms ACTH Hypasarrhythmia Adverse effects
  • 相关文献

参考文献12

  • 1Kivity S, Lerman P, Ariel R, et al. Long-term cognitive outcomes of a cohort of children with cryptogenic infantile spasms treated with high-dose adrenocorticotropic hormone. Epilepsia, 2004,45(3) :255-262. 被引量:1
  • 2Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia, 1989,30 (4) :389-399. 被引量:1
  • 3Lux AL, Osborne JP. A proposal for case definitions and ortcone neasures in studies of infantile spasms and West syndrome: Consensus statement of the West Delphi group. Epilepsia, 2004,45 ( 11 ) :1416-1428. 被引量:1
  • 4Lux AL,Osbome JP. The influence of etiology upon ictal semiology,treatment decisions and long-term outcomes in infantile spasms and West syndrome. Epilepsy Res,2006,70( Suppl 1 ) : 77-86. 被引量:1
  • 5韩彤立,邹丽萍,丁昌红,方芳,阎安平,吴沪生.妥泰治疗婴儿痉挛的疗效评估及随访观察[J].中国实用儿科杂志,2002,17(9):554-557. 被引量:18
  • 6廖建湘,肖宇寒,张蔚.脑电图高峰节律紊乱的临床意义及其变异型[J].中国当代儿科杂志,2000,2(3):148-151. 被引量:10
  • 7Rener-Pdmec Z,Stare J,Neubauer D. The risk of lower mental outcome in infantile spasms increases after three weeks of hypasarrhythmia duration . Epilepsia, 2006, 47 ( 12 ) : 2202- 2205. 被引量:1
  • 8Neto EA,Mitre AI,Gomes CM, et al. Percutaneous nephrolithotripsy with the patient in a modified supine position. J Urol, 2007,178( 1 ) :165-168. 被引量:1
  • 9左启华主编..小儿神经系统疾病[M].北京:人民卫生出版社,2002:1050.
  • 10Riikonen R. The latest on infantile spasms. Curr Opin Neurol, 2005,18(2) :91-95. 被引量:1

二级参考文献20

  • 1邹丽萍,吕中兰,秦桂先,常秀华.婴儿痉挛症的病因及预后探讨:附35例报告[J].临床儿科杂志,1994,12(4):229-230. 被引量:10
  • 2邹丽萍,吴沪生,吕中兰,秦桂先,常秀华.年龄依赖性癫痫性脑病追踪观察及分析[J].中国实用儿科杂志,1997,12(1):38-39. 被引量:2
  • 3Lin HC, Young C, Wang PJ,et al. ACTH therapy for Taiwan Residents chil- dren with West syndrome - efficacy and impact on long - term prognosis [ J ]. Brain Dev.2006.28 ( 3 ) : 196 - 201. 被引量:1
  • 4Callenbach PM, Arts WE, ten Houten R,et al. Add - on levetiracetam in ehildren and adolescents with refractory epilepsy : Results of an open - label muhi - centre study [ J ]. Eur J Paediatr Neurol, 2008,12 (4) : 321 -327. 被引量:1
  • 5Partikian A, Mitchell WG. Major adverse events associated with treatment of infantile spasms [ J ]. J Child Neurol, 2007,22 ( 12 ) : 1360 - 1366. 被引量:1
  • 6Gillard M, Chatelain P, Fuks B. Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein [ J ]. Eur J Pharmacol, 2006,536( 1 - 2 ) : 102 - 108. 被引量:1
  • 7Otoul C, de Smedt H, Stockis A. l.ack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy [ J ]. Epilepsia, 2007,48 ( 11 ) : 2111-2115. 被引量:1
  • 8Heo K, Lee BI, Yi SD,et al. Efficacy and safety of levetiracetam as adjunctive treatment of refractory partial seizures in a multicentre open - label singleann trial in Korean patients[ J]. Seizure,2007,16 (5): 402 - 409. 被引量:1
  • 9Grosso S, Cordelli DM, Franzoni E,et al. Efficacy and safety of levetiracetam in infants and young children with refractory epilepsy [ J]. Seizure,2007,16 ( 4 ) : 345 - 350. 被引量:1
  • 10Lagae L, Buyse G, Deconinck A,et al. Effect of levetiracetam in refractory childhood epilepsy syndromes [ J ]. Eur J Paediatr Neurol, 2003,7 (3) :123 - 128. 被引量:1

共引文献36

同被引文献6

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部